Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing pantoprazole, amoxicillin, and clarithromycin. It is a proton pump inhibitor (PPI) combined with two antibiotics used for the eradication of *Helicobacter pylori* (H. pylori).
## Primary Indications
* Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The typical regimen is one kit (containing pantoprazole 40 mg, amoxicillin 500 mg, and clarithromycin 500 mg) taken twice daily for 7 to 14 days. Specific duration depends on local guidelines and patient response.
## Pediatric Dosing
Dosing for children is not well-established for this specific combination product. Dosing of individual components may be considered based on age, weight, and renal/hepatic function, guided by expert consultation.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically recommended for pantoprazole, amoxicillin, or clarithromycin in mild to moderate renal impairment. Severe renal impairment may require dose reduction of amoxicillin and clarithromycin. Consult prescribing information for specific guidance.
* **Hepatic Impairment:** Pantoprazole dose may need to be reduced in severe hepatic impairment. Amoxicillin and clarithromycin generally do not require dose adjustment in hepatic impairment, but caution is advised.
## Contraindications
* Known hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or other components.
* Allergy to penicillin antibiotics.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Use in patients with congenital long QT syndrome, known QT prolongation, electrolyte imbalance, clinically significant bradycardia, or other concurrent medications that prolong the QT interval (for clarithromycin).
* Severe renal impairment with concomitant use of certain medications (e.g., certain statins) with clarithromycin.
## Adverse Effects
Common adverse effects include diarrhea, nausea, abdominal pain, headache, dizziness, rash, and taste disturbances. Serious adverse effects can include *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions, hepatic dysfunction, and QT prolongation.
## Key Drug Interactions
* **Pantoprazole:** May decrease the absorption of drugs requiring gastric acidity (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May affect absorption of vitamin B12.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives. Probenecid may decrease renal excretion of amoxicillin.
* **Clarithromycin:** Potent CYP3A4 inhibitor. Significant interactions with numerous drugs, including statins, warfarin, colchicine, certain antiarrhythmics, and anticoagulants. May increase serum concentrations of theophylline and digoxin.
## Monitoring
* Monitor for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms).
* Assess for signs of hypersensitivity reactions and *C. difficile* infection.
* Monitor liver function tests, especially with prolonged use or in patients with pre-existing liver disease.
* For patients on interacting medications, monitor for signs of toxicity or loss of efficacy.
## Clinical Pearls
* This combination product provides a convenient, fixed-dose regimen for *H. pylori* eradication.
* Ensure adequate duration of therapy as prescribed by local guidelines to maximize eradication rates and minimize resistance.
* Counsel patients on potential side effects and the importance of completing the full course of treatment.
* Consider local resistance patterns when choosing *H. pylori* eradication regimens.
***
**Disclaimer:** This information is intended for clinical use and does not replace the manufacturer's official prescribing information. Always consult the most current product labeling and relevant clinical guidelines for complete and up-to-date information.
